Glaxosmithkline pharma share price.

Glaxo Stock Analysis, Research, Glaxo Candlestick Chart Live.May 17, 2023 · Kotak Institutional Equities has initiated coverage on Mankind Pharma and given it an 'Add' rating with a target price of Rs 1,875. The brokerage expects Mankind to show significant growth in branded Rx, consumer healthcare and international segments over FY 2023-26E, leading to 15%, 22% and 26% sales, adjusted EBITDA and adjusted …Oct 11, 2023 · Glaxosmithkline Pharmaceuticals stock price went down today, 11 Oct 2023, by -0.47 %. The stock closed at 1537.75 per share. The stock is currently trading at 1530.45 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news. State Bank Of India share price 563.8 0.62% Business News / Companies / Company Results / GlaxoSmithKline Pharma Q1 profit up 11% on strong demand for vaccines

... - The Ultimate Guide · Take Me There →. SHARE PRICE MOMENTUM OF GLAXOSMITHKLINE PHARMACEUTICALS. Weekly Trend. Sharpe Ratios (>2 is Good, >3 is Excellent) 12M ...

As on 04 Dec, 2023, 03:31 PM IST Lupin share price was down by 2.78% basis the previous closing price of Rs 1,280.9. Lupin share price was Rs 1,260.55. Return Performance of Lupin Shares: 1 Week: Lupin share price moved up by 1.56%. 1 Month: Lupin share price moved up by 6.41%. 3 Month: Lupin share price moved up by 15.05%.Apr 27, 2023 · Confidence in the company’s prospects has been dimming for some time due to muted sales performance. The GSK stock has been flat, gaining just 3% over the last 5 years as supply issues and ...

Glaxosmithkline Pharmaceuticals stock price went down today, 06 Sep 2023, by -0.62 %. The stock closed at 1456 per share. The stock is currently trading at 1446.95 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.GlaxoSmithKline Pharma Share Price Target 2023: Motilal Oswal has a 'neutral' rating on the pharma major for a target price of Rs 1,300 apiece, which implies a potential upside of Rs Rs 40 per share or 3 per cent, from the current price level of Rs 1,260. GlaxoSmithKline Pharma stock price last closed at Rs 1,259.95 at NSE. Pic: …Glaxosmithkline Pharmaceuticals stock price went up today, 06 Oct 2023, by 0.68 %. The stock closed at 1539.75 per share. The stock is currently trading at 1550.25 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.Glaxosmithkline Pharmaceuticals stock price went down today, 06 Sep 2023, by -0.62 %. The stock closed at 1456 per share. The stock is currently trading at 1446.95 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.

0.91%. $257.84B. GSK | A complete GSK overview by MarketWatch. View the latest market news and prices, and trading information.

Oct 10, 2023 · Glaxosmithkline Pharmaceuticals' stock opened at ₹ 1540.25 and closed at ₹ 1550.25 on the last trading day. The stock had a high of ₹ 1565.15 and a low of ₹ 1529.6 during the day. The company's market capitalization is ₹ 25912.35 crore. The 52-week high and low for the stock are ₹ 1622.95 and ₹ 1228, respectively. The stock had a trading …

What is the Share price of Glaxosmithkline Pharmaceuticals (GLAXO)? Glaxosmithkline Pharmaceuticals (GLAXO) share price as of December 1, 2023, on NSE is Rs 1,678.15 (NSE) and Rs 1,671.00 (BSE) on BSE.Oct 9, 2023 · Glaxosmithkline Pharmaceuticals share price update :Glaxosmithkline Pharmaceuticals trading at ₹ 1547.15, up 0.27% from yesterday's ₹ 1543.05. The Glaxosmithkline Pharmaceuticals stock price is currently at ₹ 1547.15. There has been a slight increase in the stock price, with a percent change of 0.27. The net change in the stock price is 4.1. Pharma stock GSK is a remedy for the winter blahs with a low beta, a high yield, and value for investors. Sales of new drug Arexvy underpin results. ... 6 analysts have issued 1 year price objectives for GSK's stock. Their GSK share price targets range from $24.44 to $50.43. On average, they predict the company's share price to reach $37.44 …Get the latest GSK plc (GSK) stock news and headlines to help you in your trading and investing decisions.Mar 30, 2017 · GlaxoSmithkline Pharmaceuticals Ltd share price live 1,674.00, this page displays NS GLAX stock exchange data. View the GLAX premarket stock price ahead of …Oct 9, 2023 · The UK-based pharmaceutical company said Zhifei had agreed to buy £2.5bn worth of GSK’s bestselling shot, Shingrix, which is targeted at older adults, over three years. The deal includes an ...Dec 1, 2023 · GlaxoSmithKline Share Price: Find the latest news on GlaxoSmithKline Stock Price. Get all the information on GlaxoSmithKline with historic price charts for NSE / BSE. Experts & Broker view also ...

This page provides details of GSK's share price for stocks quoted on both the London and New York Stock Exchanges. By default, the page shows the London share price. To view …In today’s digital age, the need for efficient and fast file sharing has become increasingly important. One of the most significant advantages of using Xender is its lightning-fast speed when transferring files.GlaxoSmithkline Pharmaceuticals Ltd (GLAX) Get free historical data for GLAX. You'll find the closing price, open, high, low, change and %change of the %NAME_TRANS% share for the selected range of dates.Nov 16, 2023 · Glaxosmithkline Pharmaceuticals stock price went up today, 16 Nov 2023, by 2.63 %. The stock closed at 1557.9 per share. The stock is currently trading at 1598.9 per share. Investors should ... Dropbox is one of the most popular cloud storage services available today. It allows users to store and share files in the cloud, making it easy to access them from any device. With Dropbox, you can easily share files with friends, family, ...The chemical formula for calcium carbonate, which is the active ingredient in Tums, is “CaCO3,” according to GlaxoSmithKline. The active ingredient in a product is the ingredient that causes the intended effect.BSE STAR MF. BSE Institute Ltd. BSE SME Platform. BSE Startups. BSE Hi-Tech. BSE IPF. BSE Technologies. BSE BEAM. BSE SSE.

Search stock, chart, recent trades, company information, trading information, company news, fundamentals

GlaxoSmithKline Share Price: Find the latest news on GlaxoSmithKline Stock Price. Get all the information on GlaxoSmithKline with historic price charts for NSE / BSE. Experts & Broker view also ...Find the latest GSK plc (GLAXF) stock quote, history, news and other vital information to help you with your stock trading and investing.Oct 11, 2023 · The last day of Glaxosmithkline Pharmaceuticals saw an open price of ₹ 1539.95 and a close price of ₹ 1543.05. The stock reached a high of ₹ 1553.4 and a low of ₹ 1513.95. The market capitalization of the company is ₹ 26,281.65 crore. The 52-week high for the stock is ₹ 1622.95 and the 52-week low is ₹ 1228. The BSE volume for the day …GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Stock Price & News - Google Finance Markets 4,594.63 +26.83 1,862.64 Home GLAXO • NSE GlaxoSmithKline Pharmaceuticals Limited Follow Share... Oct 11, 2023 · The last day of Glaxosmithkline Pharmaceuticals saw an open price of ₹ 1539.95 and a close price of ₹ 1543.05. The stock reached a high of ₹ 1553.4 and a low of ₹ 1513.95. The market capitalization of the company is ₹ 26,281.65 crore. The 52-week high for the stock is ₹ 1622.95 and the 52-week low is ₹ 1228. The BSE volume for the day …Stock analysis for GlaxoSmithKline Pharmaceuticals Ltd (GLXO:Natl India) including stock price, stock chart, company news, key statistics, fundamentals and company profile.GlaxoSmithKline Asia Private Limited for `1,649 crores and this income formed part of the profits from discontinued operations. Accordingly, the Board was pleased to recommend a dividend of ` 90 per share which included a special dividend of ` 60 per share. Your Company launched Trelegy Ellipta, India’s first single inhaler triple therapyCompany History - GlaxoSmithKline Pharmaceuticals Ltd. 1924 - The Company was incorporated in India on 13th November under the name of H.J.Foster & Co. Limited as an Agency House for distributing the well-known Baby Food Glaxo of the then U.K. Company, Joseph Nathan & Co. two years later, the company became a wholly-owned subsidiary …GSK owns trademarks Zinetac and Zantac. It uses Zantac trademark for its ranitidine medications outside India. GSK discontinued Zinetac/Zantac 150 mg and 300 mg tablets globally in May 2020, following regulatory concerns over the presence of N-Nitrosodimethylamine (NDMA) — a probable human carcinogen in the ranitidine active …Nov 7, 2023 · Get Glaxosmithkline Pharmaceuticals Share Price, Stock Analysis, Buy/Sell Signal, Targets, Charts, Latest News, Technical Analysis, Fundamental Analysis, Live NSE/BSE Updates, Financial data and Ratios at Equitypandit.

Glaxosmithkline Pharmaceuticals Ltd. ₹ 1,645 -2.34%. 24 Nov - close price. Export to Excel. gsk-india.com BSE: 500660 NSE : GLAXO. About. GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people. (Source : Company Web-site)

Glaxosmithkline Pharmaceuticals stock price went up today, 09 Nov 2023, by 0.84 %. The stock closed at 1445.15 per share. The stock is currently trading at 1457.3 per share. Investors should ...

Dec 1, 2023 · Today, the share price of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) on NSE touched a high of Rs 1708 and a low of Rs 1669.95Nov 7, 2023 · Glaxosmithkline Pharmaceuticals stock price went down today, 07 Nov 2023, by -0.72 %. The stock closed at 1430.65 per share. The stock is currently trading at 1420.4 per share. Investors should ... 5 de jan. de 2017 ... Big Pharma companies struggled in 2016, with only five posting a share price growth. How long does it take to lose $96 billion in market value?Glaxosmithkline Pharmaceuticals stock price went down today, 25 Sep 2023, by -1.38 %. The stock closed at 1557.1 per share. The stock is currently trading at 1535.55 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.The lowest share price for GlaxoSmithKline Pharmaceuticals Limited on the National Stock Exchange in India in financial year 2023 was 1,399 rupees in February 2023. ... GSK Pharmaceuticals' share ...Nov 30, 2023 · Over this period, the share price is up 26.75%. Data delayed at least 15 minutes, as of Nov 21 2023 10:19 GMT. Latest GlaxoSmithKline Pharmaceuticals Ltd …GlaxoSmithKline Shares: Dividend & Share Price History The company has a good dividend track record and has consistently declared dividends for the last 5 years. For the fiscal year ended FY21, the company declared 300 per cent dividend amounting to Rs. 30 per share, and this at the current share price of Rs 1514.90, results in a dividend yield ...Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Aug 25, 2023 · Formula = Net Profit attributable to Equity Shareholders (TTM) / No. of Equity Shares CEPS (TTM) – Cash Earnings Per Share (Trailing Twelve Months) Formula = Net profit attributable to Equity Shareholders (TTM) + Depreciation (TTM) /No. of Equity Shares PE – Price Earnings Formula = Last Traded Price / EPS(TTM) PB – Price to Book Value

The stock is currently trading at 1463 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news. On the last day, Glaxosmithkline Pharmaceuticals opened at ₹ 1446.1 and closed at ₹ 1446.45. The stock's high for the day was ₹ 1468 and the low was ...Nov 29, 2023 · The share price for GlaxoSmithKline Pharmaceuticals Ltd. is ₹1,631.00 as on Nov 29, 2023. What are the 52 Week High and 52 Week Low of GlaxoSmithKline Pharmaceuticals Ltd.? 1 day ago · 2023 was marked by several first-time approvals, while some previously approved drugs came under scrutiny. by Bethany Halford. If 2022 was a sparse year for …0.91%. $257.84B. GSK | A complete GSK overview by MarketWatch. View the latest market news and prices, and trading information.Instagram:https://instagram. xlk top holdingsbulgari thin watchbanks that invest your moneymagnificent 7 stocks Glaxosmithkline Pharmaceuticals stock price went down today, 21 Sep 2023, by -0.62 %. The stock closed at 1568.7 per share. The stock is currently trading at 1559 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news. best loans for seniors on social securitystock expert UK multinational pharmaceutical and biotechnology firm GlaxoSmithKline (GSK) has underperformed the market in the past year as it faces US litigation and high inflation driving up costs. The GSK share price has fallen by 14% in the past year, compared with a 1% rise in the FTSE 100 Index (UK100), a 38% gain for UK rival Astrazeneca ( AZN ) and ...GSK’s share price has fallen 13% to £14.39 since Walmsley took over four years ago. ... It rejected Elliott’s demand to keep pharmaceuticals and vaccines separate after the shake-up, saying ... bulletshares bond ladder 26 de nov. de 2023 ... The average one-year price target for GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) has been revised to 1586.78 / share.The merger helped the combined firm to achieve economies of scale in the pharmaceutical sector. GlaxoSmithKline Beecham (GSK) became the largest pharmaceutical company in the world. ... and each SmithKline Beecham shareholder received 0.4552 GlaxoSmithKline Shares. The nominal value of the shares issued was …This page provides details of GSK's share price for stocks quoted on both the London and New York Stock Exchanges. By default, the page shows the London share price. To view US ADR data, click on the ADR tab below. London ADR You might also like Shareholder information Here you will find information and tools for GSK shareholders including our…